Cardiac function in adolescents and young adults with 22q11.2 deletion syndrome without congenital heart disease
Background
Diagnosis and treatment of 22q11.2 deletion syndrome (22q11.2DS) have led to improved life expectancy and achievement of adulthood. Limited data on long-term outcomes reported an increased risk of premature death for cardiovascular causes, even without congenital heart disease (CHD).